Uric acid-lowering effects of sodium-glucose cotransporter 2 inhibitors for preventing cardiovascular events and mortality: A systematic review and meta-analysis.

Published in: Diabetes, obesity & metabolism (2024)

SGLT2 inhibitors reduced UA levels and cardiovascular events independently of heart failure status.

Keyphrases